Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study.
OBJECTIVE
Our aim was to evaluate the impact of metabolic syndrome (MetS) on cardiac phenotype in adolescents.


BACKGROUND
A high prevalence of MetS has been reported in adolescents.


METHODS
Four hundred forty-six nondiabetic American Indian adolescents (age 14 to 20 years, 238 girls) underwent clinical evaluation, laboratory testing, and Doppler echocardiography. Age- and gender-specific partition values were used to define obesity and hypertension. Metabolic syndrome was defined according to Adult Treatment Panel III criteria, modified for adolescents. Left ventricular (LV) hypertrophy and left atrial (LA) dilation were identified using age- and gender-specific partition values.


RESULTS
One hundred eleven participants met criteria for MetS. They had a similar age and gender distribution as non-MetS participants. Analysis of covariance, controlling for relevant confounders, demonstrated that participants with MetS had higher LV, LA, and aortic root diameters, higher LV relative wall thickness, and greater LV mass index. Accordingly, MetS participants showed higher prevalences of LV hypertrophy (43.2% vs. 11.7%) and LA dilation (63.1% vs. 21.9%, both p < 0.001) compared with non-MetS participants. In addition, MetS was associated with a reduction in midwall shortening, lower transmitral mitral early to atrial peak velocity ratio, and mildly prolonged mitral early deceleration time (all p < 0.05). In multiple regression analysis, independently of demographics, obesity, blood pressure, and single metabolic components of MetS, clustered MetS was associated with a 2.6-fold higher likelihood of LV hypertrophy and a 2.3-fold higher likelihood of LA dilation (both p < or = 0.02).


CONCLUSIONS
In a population sample of adolescents, MetS is associated with higher prevalences of LV hypertrophy and LA dilation and with reduced LV systolic and diastolic function, independently of individual MetS components.
Chinali
Marcello
M
Department of Clinical and Experimental Medicine, Federico II University Hospital School of Medicine, Naples, Italy. mchinali@unina.it
de Simone
Giovanni
G
Roman
Mary J
MJ
Best
Lyle G
LG
Lee
Elisa T
ET
Russell
Marie
M
Howard
Barbara V
BV
Devereux
Richard B
RB
D000293:Adolescent; D000328:Adult; D005260:Female; D006304:Health Status; D006321:Heart / Q000503:physiopathology*; D006325:Heart Atria / Q000473:pathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology*; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D009206:Myocardium / Q000473:pathology*; D012307:Risk Factors
Circulation. 2002 Dec 17;106(25):3143-421
12485966
J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
2698218
J Clin Endocrinol Metab. 2006 Aug;91(8):2906-12
16735483
J Am Coll Cardiol. 1992 Nov 1;20(5):1251-60
1401629
Am J Epidemiol. 1990 Dec;132(6):1141-55
2260546
Am J Clin Nutr. 1991 Mar;53(3):594-8
2000812
Arch Dis Child. 2007 Dec;92(12):1067-72
17301109
N Engl J Med. 2004 Jun 3;350(23):2362-74
15175438
Circulation. 1995 Dec 1;92(11):3249-54
7586311
JAMA. 2003 May 21;289(19):2560-72
12748199
JAMA. 2002 Dec 4;288(21):2709-16
12460094
Arch Intern Med. 1993 Jan 25;153(2):154-83
8422206
Diabetes Care. 2007 Jul;30(7):1851-6
17440172
Am J Epidemiol. 2002 Dec 1;156(11):1070-7
12446265
Am J Cardiol. 1986 Feb 15;57(6):450-8
2936235
Am J Clin Nutr. 1991 Apr;53(4):839-46
2008861
Diabetes Care. 2007 Jan;30(1):8-13
17192325
Atherosclerosis. 2008 Jul;199(1):193-200
18031749
Am Heart J. 1999 Jul;138(1 Pt 1):122-7
10385774
Mayo Clin Proc. 2006 Dec;81(12):1615-20
17165640
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Int J Obes (Lond). 2008 Jan;32(1):91-9
18193066
J Am Coll Cardiol. 2006 Jun 6;47(11):2267-73
16750694
J Am Coll Cardiol. 2007 May 29;49(21):2112-9
17531661
J Clin Endocrinol Metab. 2007 Feb;92(2):399-404
17284640
Vital Health Stat 11. 2002 May;(246):1-190
12043359
Am J Epidemiol. 1995 Aug 1;142(3):254-68
7631630
Am Heart J. 1990 Jul;120(1):116-23
2360495
Circulation. 1996 Jan 15;93(2):259-65
8548897
JAMA. 2006 Apr 5;295(13):1549-55
16595758
Lancet. 2005 Oct 1;366(9492):1197-209
16198769
J Pediatr. 2002 Aug;141(2):186-90
12183712
J Pediatr. 2004 Oct;145(4):445-51
15480365
Pediatr Diabetes. 2006 Feb;7(1):39-44
16489973
Circulation. 1978 Dec;58(6):1072-83
709763
Cardiol Clin. 2004 Nov;22(4):485-504
15501618
Hypertension. 2005 Jan;45(1):64-8
15557389
Circulation. 1997 Sep 2;96(5):1416-23
9315526
Cent Eur J Public Health. 2006 Dec;14(4):151-9
17243492
Lancet. 2007 Jun 23;369(9579):2059-61
17586288
Am J Cardiol. 2004 Jan 1;93(1):40-4
14697463
Circulation. 2007 May 1;115(17):2316-22
17420347
J Hum Hypertens. 2007 Aug;21(8):625-32
17476291
J Am Coll Cardiol. 2007 Feb 27;49(8):891-8
17320748